To Evaluate the Performance of Total 30 (Lehifilcon A) Contact Lenses in Patients Using Digital Devices for Greater Than 8 Hours Per Day 5 Days Per Week Based on Subjective Reported Data.

Tauber Eye Center

Status

Completed

Conditions

Eye Strain

Treatments

Device: Total 30 Contact Lens

Study type

Interventional

Funder types

Other

Industry

Identifiers

NCT06317038

89814415

Details and patient eligibility

About

To evaluate the performance of Total 30® (lehfilcon A) contact lenses in patients using digital devices for greater than 8 hours per day 5 days per week based on subjective reported data.

Enrollment

35 patients

Sex

All

Ages

18 to 40 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

Adult patients aged 18-40 of any sex and any race.
Reports habitually using digital device usage (phone, Ipad, computer, social media, video streaming) for 8 hours or more per day 5 days per week with plans to continue the habit throughout the study.
Wearing contact lenses for at least 13 hours daily 5 days per week.
Spherical refractive error between -11.00 D and +6.00D with < -0.75 D of astigmatism.
Willing to comply with the protocol instructions.
Has read (or has had read to), understood, and signed an Informed Consent.
Willing to not use any artificial tears, rewetting drops or dry eye treatments during the study.

Exclusion criteria

Active ocular infection or ocular inflammatory disease.
Presbyopic or pre-presbyopic that have a measured add power for reading.
Current Total 30 contact lens wearer.
Anterior basement membrane dystrophy or history of recurrent erosion syndrome or topographical abnormalities that might indicate ectasia or other corneal degenerative conditions.
Current or previous diagnosis of dry eye disease; currently using a dry eye treatment including but not limited to artificial tears, rewetting drops or prescription treatments.
History of severe / serious ocular pathology or other medical conditions that could result in an inability to safely complete the study.
Participation by the patient in any other investigational study within the past 30 days.
Unlikely to comply with protocol instructions for any reason (confusion, substance abuse, etc.). The Principal Investigator or the Medical Monitor reserves the right to declare a patient ineligible based on medical evidence that indicates the patient is unsuitable for the study.
Inability to utilize Clear Care Cleaning solution.
Pregnancy